company background image
GMRE

Global Medical REITNYSE:GMRE Stock Report

Market Cap

US$1.1b

7D

-1.9%

1Y

18.4%

Updated

02 Dec, 2021

Data

Company Financials +
GMRE fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health1/6
Dividends3/6

GMRE Stock Overview

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Global Medical REIT Competitors

Welltower

NYSE:WELL

US$34.5b

Ventas

NYSE:VTR

US$18.4b

Healthpeak Properties

NYSE:PEAK

US$17.8b

Medical Properties Trust

NYSE:MPW

US$12.4b

Price History & Performance

Summary of all time highs, changes and price drops for Global Medical REIT
Historical stock prices
Current Share PriceUS$16.59
52 Week HighUS$17.40
52 Week LowUS$12.40
Beta0.81
1 Month Change-0.90%
3 Month Change4.41%
1 Year Change18.42%
3 Year Change67.75%
5 Year Change94.04%
Change since IPO-96.63%

Recent News & Updates

Oct 20

Global Medical REIT And Medical Properties Are Clear Winners In The Mispriced Healthcare Sector

Stock multiples should be based on forward growth and risk level. In the healthcare REIT sector, however, there seems to be no correlation between fundamentals and price. This creates opportunity in that some of the names are deeply undervalued.

Oct 04

The Growth Story Remains Intact At Global Medical REIT

Global Medical REIT has done well in the last 12 months. It continues to outperform peers and we look at whether that has made it expensive. Key considerations though revolve around the secondary assets.

Shareholder Returns

GMREUS REITsUS Market
7D-1.9%-2.6%-3.5%
1Y18.4%28.4%19.4%

Return vs Industry: GMRE underperformed the US REITs industry which returned 28.4% over the past year.

Return vs Market: GMRE underperformed the US Market which returned 19.4% over the past year.

Price Volatility

Is GMRE's price volatile compared to industry and market?
GMRE volatility
GMRE Average Weekly Movement2.8%
REITs Industry Average Movement3.6%
Market Average Movement6.1%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: GMRE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: GMRE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201122Jeff Buschhttps://www.globalmedicalreit.com

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Global Medical REIT Fundamentals Summary

How do Global Medical REIT's earnings and revenue compare to its market cap?
GMRE fundamental statistics
Market CapUS$1.06b
Earnings (TTM)US$9.06m
Revenue (TTM)US$110.52m

120.7x

P/E Ratio

9.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GMRE income statement (TTM)
RevenueUS$110.52m
Cost of Revenue-US$121.00k
Gross ProfitUS$110.64m
ExpensesUS$101.58m
EarningsUS$9.06m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.14
Gross Margin100.11%
Net Profit Margin8.20%
Debt/Equity Ratio89.9%

How did GMRE perform over the long term?

See historical performance and comparison

Dividends

4.9%

Current Dividend Yield

102%

Payout Ratio

Valuation

Is Global Medical REIT undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GMRE ($16.59) is trading below our estimate of fair value ($54.13)

Significantly Below Fair Value: GMRE is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GMRE is poor value based on its PE Ratio (120.7x) compared to the US REITs industry average (45.8x).

PE vs Market: GMRE is poor value based on its PE Ratio (120.7x) compared to the US market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: GMRE is poor value based on its PEG Ratio (3.6x)


Price to Book Ratio

PB vs Industry: GMRE's PB Ratio (2x) is in line with the US REITs industry average.


Future Growth

How is Global Medical REIT forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

33.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: GMRE's forecast earnings growth (33.4% per year) is above the savings rate (2%).

Earnings vs Market: GMRE's earnings (33.4% per year) are forecast to grow faster than the US market (14.1% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: GMRE's revenue (16.6% per year) is forecast to grow faster than the US market (10% per year).

High Growth Revenue: GMRE's revenue (16.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if GMRE's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Global Medical REIT performed over the past 5 years?

17.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GMRE has high quality earnings.

Growing Profit Margin: GMRE became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: GMRE has become profitable over the past 5 years, growing earnings by 17.3% per year.

Accelerating Growth: GMRE has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: GMRE has become profitable in the last year, making it difficult to compare its past year earnings growth to the REITs industry (27.7%).


Return on Equity

High ROE: GMRE's Return on Equity (2.5%) is considered low.


Financial Health

How is Global Medical REIT's financial position?


Financial Position Analysis

Short Term Liabilities: GMRE's short term assets ($50.4M) exceed its short term liabilities ($38.5M).

Long Term Liabilities: GMRE's short term assets ($50.4M) do not cover its long term liabilities ($574.5M).


Debt to Equity History and Analysis

Debt Level: GMRE's net debt to equity ratio (88.9%) is considered high.

Reducing Debt: GMRE's debt to equity ratio has increased from 25.4% to 89.9% over the past 5 years.

Debt Coverage: GMRE's debt is not well covered by operating cash flow (12%).

Interest Coverage: GMRE's interest payments on its debt are not well covered by EBIT (1.8x coverage).


Balance Sheet


Dividend

What is Global Medical REIT current dividend yield, its reliability and sustainability?

4.94%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: GMRE's dividend (4.94%) is higher than the bottom 25% of dividend payers in the US market (1.35%).

High Dividend: GMRE's dividend (4.94%) is in the top 25% of dividend payers in the US market (3.61%)


Stability and Growth of Payments

Stable Dividend: GMRE has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: GMRE's dividend payments have increased, but the company has only paid a dividend for 7 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (101.6%), GMRE's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: GMRE's dividends in 3 years are forecast to be covered by earnings (63.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.6yrs

Average management tenure


CEO

Jeff Busch (61 yo)

4.33yrs

Tenure

US$3,086,109

Compensation

Mr. Jeffrey M. Busch, also known as Jeff, is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharmaceuticals, Inc.). since June 2020. He is the Chairman of Avant Diagnos...


CEO Compensation Analysis

Compensation vs Market: Jeff's total compensation ($USD3.09M) is above average for companies of similar size in the US market ($USD2.36M).

Compensation vs Earnings: Jeff's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: GMRE's management team is considered experienced (4.6 years average tenure).


Board Members

Experienced Board: GMRE's board of directors are considered experienced (5.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.4%.


Top Shareholders

Company Information

Global Medical REIT Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Global Medical REIT Inc.
  • Ticker: GMRE
  • Exchange: NYSE
  • Founded: 2011
  • Industry: Health Care REITs
  • Sector: Real Estate
  • Implied Market Cap: US$1.062b
  • Market Cap: US$1.035b
  • Shares outstanding: 65.91m
  • Website: https://www.globalmedicalreit.com

Number of Employees


Location

  • Global Medical REIT Inc.
  • 2 Bethesda Metro Center
  • Suite 440
  • Bethesda
  • Maryland
  • 20814
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/02 23:43
End of Day Share Price2021/12/02 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.